Whitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference

Rhea-AI Summary

Whitehawk Therapeutics (Nasdaq: WHWK), a company focused on developing advanced ADC cancer treatments, has announced its participation in the upcoming BTIG Virtual Biotechnology Conference. The conference is scheduled for July 29-30, 2025, where the company's management will present their developments in oncology therapeutics and ADC technology.

News Market Reaction – WHWK

+1.08%

+1.08% Session move

In the trading session that priced this news, WHWK gained 1.08%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MORRISTOWN, N.J., July 22, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments, announced today that the Company's management will participate in the BTIG Virtual Biotechnology Conference being held on July 29-30, 2025.

About Whitehawk Therapeutics 

Whitehawk Therapeutics is an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Whitehawk's advanced three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed from WuXi Biologics under an exclusive development and global commercialization agreement. More information on the Company is available at www.whitehawktx.com and connect with us on LinkedIn.

Contact
IR@whitehawktx.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/whitehawk-therapeutics-to-participate-in-the-btig-virtual-biotechnology-conference-302509852.html

SOURCE Whitehawk Therapeutics, Inc.

FAQ

When is Whitehawk Therapeutics (WHWK) presenting at the BTIG Virtual Biotechnology Conference?

Whitehawk Therapeutics will participate in the BTIG Virtual Biotechnology Conference on July 29-30, 2025.

What is Whitehawk Therapeutics' (WHWK) main business focus?

Whitehawk Therapeutics is an oncology therapeutics company that applies advanced technologies to established tumor biology to develop improved ADC cancer treatments.

How can investors access Whitehawk Therapeutics' (WHWK) BTIG conference presentation?

The press release does not specify access details for the BTIG Virtual Biotechnology Conference presentation. Investors should check WHWK's investor relations website for more information.

Where is Whitehawk Therapeutics (WHWK) headquartered?

Whitehawk Therapeutics is headquartered in Morristown, New Jersey.